Zyklosporine

European patent · EP0484281 · Deleted

Register entry

Publication number
EP0484281
Application number
EP91810841
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Maintained in amended form
Filed
Oct 30, 1991
Published
May 6, 1992
Granted
Jan 29, 1997
Deleted
Oct 29, 2011
Reason
Maximum term reached
IPC classes
C07K 7/64 (2006.01)
A61K 38/12 (2006.01)
C12P 21/04 (2006.01)
*C12P 21/04 (2006.01)
Priority
GB 9023859 02.11.1990
GB 9023972 05.11.1990
GB 9023970 05.11.1990
GB 9023971 05.11.1990
GB 9116836 05.08.1991
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 31, 2011

    Maximum term reached

    Published in Swissreg on 31.10.2011

  2. Dec 15, 2000

    Change

    Published in PIDTJ No 23 in 2000

  3. May 15, 1997

    Address changed

    Owner
    SANDOZ LTD., Lichtstrasse 35, 4002 Basel → Novartis AG, Schwarzwaldallee 215, 4058 Basel

    Published in PIDTJ No 9 in 1997

  4. Jan 31, 1997

    Granted

    Published in PIDTJ No 2 in 1997

Parties

Holder

Novartis AG

Schwarzwaldallee 215, 4058 Basel

Inventor

Ko, Soo Young

London NW3 4LY, GB

Kobel, Hans

CH-4059 Basle

Rosenwirth, Brigitte

A-2340 Mödling, AT

Seebach, Dieter

CH-8044 Zürich

Traber, René P.

CH-4052 Basle

Wenger, Roland

CH-4125 Riehen

Bollinger, Pietro

CH-4103 Bottmingen

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.